The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gosselin, E. J.
Right arrow Articles by Guyre, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gosselin, E. J.
Right arrow Articles by Guyre, P. M.

The Journal of Immunology, Vol 149, Issue 11 3477-3481, Copyright © 1992 by American Association of Immunologists


ARTICLES

Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens

EJ Gosselin, K Wardwell, DR Gosselin, N Alter, JL Fisher and PM Guyre
Department of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.

A major new challenge for vaccine development is to target APC such as monocytes and macrophages for efficient Ag processing and presentation. It has been shown that Fc gamma R-mediated uptake of Ag-antibody complexes can enhance Ag presentation by myeloid cells at least 100- fold, and directing Ag to Fc gamma R in mice brings about a substantial increase in the effectiveness of immunization while eliminating the requirement for adjuvant. It has not been determined which of the three subclasses of human Fc gamma R on myeloid cells (Fc gamma RI, Fc gamma RII, or Fc gamma RIII) function to enhance Ag presentation. We have targeted our Ag (TT) to each of the three subclasses of human Fc gamma R on monocytes using Fc gamma R subclass-specific mAb-TT conjugates, and have measured TT presentation by monitoring T cell proliferation in response to TT. In addition, we have examined enhanced Ag presentation mediated by a human IgG1 (HIgG1) anti-TT mAb. All anti-Fc gamma R-TT conjugates enhanced Ag presentation. HIgG1 anti-TT, in monomeric form, enhanced Ag presentation through Fc gamma RI only. Anti-Fc gamma RI-Ag conjugates appear to be optimal for application as vaccines. They are monocyte/macrophage-specific, are very efficiently processed and presented, and enhance Ag presentation despite occupation of Fc gamma RI with HIgG.


This article has been cited by other articles:


Home page
J. Virol.Home page
L. G. Perez, M. R. Costa, C. A. Todd, B. F. Haynes, and D. C. Montefiori
Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41
J. Virol., August 1, 2009; 83(15): 7397 - 7410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion
J. Immunol., July 15, 2008; 181(2): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. B. Rawool, C. Bitsaktsis, Y. Li, D. R. Gosselin, Y. Lin, N. V. Kurkure, D. W. Metzger, and E. J. Gosselin
Utilization of Fc Receptors as a Mucosal Vaccine Strategy against an Intracellular Bacterium, Francisella tularensis
J. Immunol., April 15, 2008; 180(8): 5548 - 5557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Liu, X. Gao, E. Masuda, P. B. Redecha, M. C. Blank, and L. Pricop
Regulated Expression of Fc{gamma}R in Human Dendritic Cells Controls Cross-Presentation of Antigen-Antibody Complexes
J. Immunol., December 15, 2006; 177(12): 8440 - 8447.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. Abdel-Motal, S. Wang, S. Lu, K. Wigglesworth, and U. Galili
Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Gal{alpha}1-3Gal{beta}1-4GlcNAc-R Epitopes
J. Virol., July 15, 2006; 80(14): 6943 - 6951.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. A. Lang and M. L. Lang
Protein Kinase B{alpha} Is Required for Vesicle Trafficking and Class II Presentation of IgA Fc Receptor (CD89)-Targeted Antigen
J. Immunol., April 1, 2006; 176(7): 3987 - 3994.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-Z. Shi
Eosinophils function as antigen-presenting cells
J. Leukoc. Biol., September 1, 2004; 76(3): 520 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Beekman, J. E. Bakema, J. van der Linden, B. Tops, M. Hinten, M. van Vugt, J. G. J. van de Winkel, and J. H. W. Leusen
Modulation of Fc{gamma}RI (CD64) Ligand Binding by Blocking Peptides of Periplakin
J. Biol. Chem., August 6, 2004; 279(32): 33875 - 33881.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Yang, I. Tikhonov, T. J. Ruckwardt, M. Djavani, J. C. Zapata, C. D. Pauza, and M. S. Salvato
Monocytes Treated with Human Immunodeficiency Virus Tat Kill Uninfected CD4+ Cells by a Tumor Necrosis Factor-Related Apoptosis-Induced Ligand-Mediated Mechanism
J. Virol., June 15, 2003; 77(12): 6700 - 6708.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. A. Jordan, M. T. Preissler, J. A. Banas, and E. J. Gosselin
Production of Genetically Engineered Biotinylated Interleukin-2 and Its Application in a Rapid Nonradioactive Assay for T-Cell Activation
Clin. Vaccine Immunol., May 1, 2003; 10(3): 339 - 344.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. van Spriel, H. H. van Ojik, A. Bakker, M. J. H. Jansen, and J. G. J. van de Winkel
Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma
Blood, January 1, 2003; 101(1): 253 - 258.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. El-Amine, J. A. Hinshaw, and D. W. Scott
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment
Int. Immunol., July 1, 2002; 14(7): 761 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Mold, B. Rodic-Polic, and T. W. Du Clos2
Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fc{gamma} Receptors
J. Immunol., June 15, 2002; 168(12): 6375 - 6381.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Kronenberger, A. Dieckmann, M. Selmayr, J. Strehl, U. Wahl, H. Lindhofer, G. Kraal, and R. Mocikat
Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells
Blood, February 15, 2002; 99(4): 1327 - 1331.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Guyre, T. Keler, S. L. Swink, L. A. Vitale, R. F. Graziano, and M. W. Fanger
Receptor Modulation by Fc{gamma}RI-Specific Fusion Proteins Is Dependent on Receptor Number and Modified by IgG
J. Immunol., December 1, 2001; 167(11): 6303 - 6311.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. MacKenzie, J. Mattes, L. A. Dent, and P. S. Foster
Eosinophils Promote Allergic Disease of the Lung by Regulating CD4+ Th2 Lymphocyte Function
J. Immunol., September 15, 2001; 167(6): 3146 - 3155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. B. van Spriel, I. E. van den Herik-Oudijk, and J. G. J. van de Winkel
Neutrophil Fc{{gamma}}RI as Target for Immunotherapy of Invasive Candidiasis
J. Immunol., June 15, 2001; 166(12): 7019 - 7022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Guyre, M. E. Barreda, S. L. Swink, and M. W. Fanger
Colocalization of Fc{{gamma}}RI-Targeted Antigen With Class I MHC: Implications for Antigen Processing
J. Immunol., February 15, 2001; 166(4): 2469 - 2478.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Shen, M. van Egmond, K. Siemasko, H. Gao, T. Wade, M. L. Lang, M. Clark, J. G. J. van de Winkel, and W. F. Wade
Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor is enhanced through Fc receptor {gamma}-chain signaling
Blood, January 1, 2001; 97(1): 205 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Keler, P. M. Guyre, L. A. Vitale, K. Sundarapandiyan, J. G. J. van de Winkel, Y. M. Deo, and R. F. Graziano
Targeting Weak Antigens to CD64 Elicits Potent Humoral Responses in Human CD64 Transgenic Mice
J. Immunol., December 15, 2000; 165(12): 6738 - 6742.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T.-H. Huang, P.-Y. Wu, C.-N. Lee, H.-I Huang, S.-L. Hsieh, J. Kung, and M.-H. Tao
Enhanced antitumor immunity by fusion of CTLA-4 to a self tumor antigen
Blood, December 1, 2000; 96(12): 3663 - 3670.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Hamano, H. Arase, H. Saisho, and T. Saito
Immune Complex and Fc Receptor-Mediated Augmentation of Antigen Presentation for in Vivo Th Cell Responses
J. Immunol., June 15, 2000; 164(12): 6113 - 6119.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T Lovdal, E Andersen, A Brech, and T Berg
Fc receptor mediated endocytosis of small soluble immunoglobulin G immune complexes in Kupffer and endothelial cells from rat liver
J. Cell Sci., January 9, 2000; 113(18): 3255 - 3266.
[Abstract] [PDF]


Home page
BloodHome page
K. L. Murad, E. J. Gosselin, J. W. Eaton, and M. D. Scott
Stealth Cells: Prevention of Major Histocompatibility Complex Class II-Mediated T-Cell Activation by Cell Surface Modification
Blood, September 15, 1999; 94(6): 2135 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Wernersson, M. C. I. Karlsson, J. Dahlstrom, R. Mattsson, J. S. Verbeek, and B. Heyman
IgG-Mediated Enhancement of Antibody Responses Is Low in Fc Receptor {gamma} Chain-Deficient Mice and Increased in Fc{gamma}RII-Deficient Mice
J. Immunol., July 15, 1999; 163(2): 618 - 622.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. C. LaTemple, J. T. Abrams, S. Y. Zhang, and U. Galili
Increased Immunogenicity of Tumor Vaccines Complexed with Anti-Gal: Studies in Knockout Mice for {{alpha}}1,3Galactosyltransferase
Cancer Res., July 1, 1999; 59(14): 3417 - 3423.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. S. Griffith, S. R. Wiley, M. Z. Kubin, L. M. Sedger, C. R. Maliszewski, and N. A. Fanger
Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor-related Cytokine, TRAIL
J. Exp. Med., April 19, 1999; 189(8): 1343 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Coccia and P. Brams
High Titer, Prostate Specific Antigen-Specific Human IgG Production by hu-PBL-SCID Mice Immunized with Antigen-Mouse IgG2a Complex-Pulsed Autologous Dendritic Cells
J. Immunol., November 15, 1998; 161(10): 5772 - 5780.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Maurer, E. Fiebiger, B. Reininger, C. Ebner, P. Petzelbauer, G.-P. Shi, H. A. Chapman, and G. Stingl
Fc{epsilon} Receptor I on Dendritic Cells Delivers IgE-Bound Multivalent Antigens into a Cathepsin S-Dependent Pathway of MHC Class II Presentation
J. Immunol., September 15, 1998; 161(6): 2731 - 2739.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Van Weyenbergh, P. Lipinski, A. Abadie, D. Chabas, U. Blank, R. Liblau, and J. Wietzerbin
Antagonistic Action of IFN-{beta} and IFN-{gamma} on High Affinity Fc{gamma} Receptor Expression in Healthy Controls and Multiple Sclerosis Patients
J. Immunol., August 1, 1998; 161(3): 1568 - 1574.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Leonetti, R. Thai, J. Cotton, S. Leroy, P. Drevet, F. Ducancel, J. C. Boulain, and A. Menez
Increasing Immunogenicity of Antigens Fused to Ig-Binding Proteins by Cell Surface Targeting
J. Immunol., April 15, 1998; 160(8): 3820 - 3827.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. A. Fanger, C. Liu, P. M. Guyre, K. Wardwell, J. O'Neil, T. L. Guo, T. P. Christian, S. P. Mudzinski, and E. J. Gosselin
Activation of Human T Cells by Major Histocompatability Complex Class II Expressing Neutrophils: Proliferation in the Presence of Superantigen, But Not Tetanus Toxoid
Blood, June 1, 1997; 89(11): 4128 - 4135.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. Hall
Prospects for a respiratory syncytial virus vaccine
Science, September 2, 1994; 265(5177): 1393 - 1394.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.